Mitsubishi Tanabe Pharma Corp - Company Profile

Powered by

All the data and insights you need on Mitsubishi Tanabe Pharma Corp in one report.

  • Save hours of research time and resources with
    our up-to-date Mitsubishi Tanabe Pharma Corp Strategy Report

  • Understand Mitsubishi Tanabe Pharma Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Mitsubishi Tanabe Pharma Corp: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Mitsubishi Tanabe Pharma Corp Clinical Trials

Determine Mitsubishi Tanabe Pharma Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of Mitsubishi Tanabe Pharma Corp Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 410+ results.
Deserunt mollit sunt Lorem GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Pfizer Inc
Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects with ALS GDCT0468094 edaravone Central Nervous System Amyotrophic Lateral Sclerosis Phase III Ongoing, recruiting Mitsubishi Tanabe Pharma Corp
Early Post-marketing Phase Vigilance Study of Dysval Capsules 40 mg (Valbenazine Tosilate) GDCT0464626 valbenazine tosylate Central Nervous System Tardive Dyskinesia Phase IV Planned Mitsubishi Tanabe Pharma Corp
An Investigator-initiated Trial Evaluating the Efficacy and Safety of Valixa in Children with Symptomatic Congenital Cytomegalovirus Infection (VGCV-1) GDCT0460191 valganciclovir hydrochloride Infectious Disease Cytomegalovirus (HHV-5) Infections Phase II Completed Mitsubishi Tanabe Pharma Corp
Clinical Trials

Feature

GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.

Benefit

The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).

Access:

  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.

Value

Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Gain a 360-degree view of Mitsubishi Tanabe Pharma Corp and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer